Advertisement
Screener

OMEROS CORP (OMER) ROA

OMEROS CORP (OMER) ROA

  • 2026-06-30: ROA 43.52%.
  • 2026-03-31: ROA 30.11%.
  • 2025-12-31: ROA -1.03%.
  • 2025-09-30: ROA -65.24%.

Complete source-backed roa history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-3043.52%
2026-03-3130.11%
2025-12-31-1.03%
2025-09-30-65.24%
2025-06-30-61.06%
2025-03-31-65.10%
2024-12-31-56.60%
2024-09-30-42.93%
2024-06-30-39.30%
2024-03-31-27.73%
2023-12-31-31.15%
2023-09-304.05%
2023-06-307.64%
2023-03-318.34%
2022-12-318.02%
2022-09-3043.56%
2022-06-3056.14%
2022-03-3153.16%
2021-12-3146.33%
2021-09-30-100.19%
2021-06-30-95.89%
2021-03-31-89.27%
2020-12-31-76.26%
2020-09-30-57.26%
2020-06-30-152.80%
2020-03-31-75.43%
2019-12-31-61.68%
2019-09-30-86.34%
2019-06-30-113.42%
2019-03-31-119.56%
2018-12-31-132.13%
2018-09-30-158.41%
2018-06-30-82.54%
2018-03-31-76.88%
2017-12-31-45.97%
2017-09-30-45.06%
2017-06-30-104.45%
2017-03-31-104.95%
2016-12-31-99.21%
2016-09-30-92.00%
2016-06-30-158.10%
2016-03-31-213.96%
2015-12-31-153.27%
2015-09-30-183.46%
2015-06-30-126.86%
2015-03-31-101.05%
2014-12-31-680.02%
2014-09-30-216.67%
2014-06-30-122.82%
2014-03-31-81.95%
2013-12-31-240.68%
2013-09-30-380.26%
2013-06-30-195.55%
2013-03-31-226.29%
2012-12-31-144.66%
2012-09-30-124.88%
2012-06-30-339.23%
2012-03-31-146.52%
2011-12-31-105.80%
2011-09-30-73.11%
2011-06-30-65.01%

Annual ROA

DateROA
2025-12-31-1.03%
2024-12-31-56.60%
2023-12-31-31.15%
2022-12-318.02%
2021-12-3146.33%
2020-12-31-76.26%
2019-12-31-61.68%
2018-12-31-132.13%
2017-12-31-45.97%
2016-12-31-99.21%
2015-12-31-153.27%
2014-12-31-680.02%
2013-12-31-240.68%
2012-12-31-144.66%
2011-12-31-105.80%
2010-12-31-64.00%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Innoviva, Inc. (INVA)United States$1.493B4.62
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Kardigan, Inc. (KARD)United States$1.346B
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82